β-Blocker and survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease
Eur Heart J
.
2021 Mar 21;42(12):1180.
doi: 10.1093/eurheartj/ehab004.
Authors
Hui Tang
1
,
Zu-Yao Yang
2
,
Jin-Ling Tang
1
2
Affiliations
1
Department of Clinical Data Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
2
Division of Epidemiology, JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong, China.
PMID:
33495780
DOI:
10.1093/eurheartj/ehab004
No abstract available
Publication types
Comment
MeSH terms
Adrenergic beta-Antagonists / therapeutic use
Cardiovascular Diseases*
Humans
Lung
Substances
Adrenergic beta-Antagonists